Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (SHE:300534)

China flag China · Delayed Price · Currency is CNY
7.46
-0.12 (-1.58%)
Jun 11, 2026, 3:04 PM CST
Market Cap2.26B -20.4%
Revenue (ttm)843.87M -20.6%
Net Income49.37M +129.2%
EPS0.16 +129.1%
Shares Out 303.35M
PE Ratio45.83
Forward PEn/a
Dividend0.04 (0.53%)
Ex-Dividend DateMay 22, 2026
Volume3,953,600
Open7.56
Previous Close7.58
Day's Range7.33 - 7.62
52-Week Range7.34 - 12.90
Beta0.43
Analystsn/a
Price Targetn/a
Earnings DateAug 21, 2026

About SHE:300534

Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally. It is also involved in the cultivation, processing, and sales of chemical drugs and medicinal herbs, as well as pharmaceutical distribution, testing, and inspection services. The company was founded in 2002 and is based in Lanzhou, China. [Read more]

Sector Healthcare
Founded 2002
Employees 641
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300534
Full Company Profile

Financial Performance

In 2025, SHE:300534's revenue was 886.96 million, a decrease of -14.92% compared to the previous year's 1.04 billion. Earnings were 43.95 million, an increase of 79.56%.

Financial Statements